We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-0.98%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$876M
AUM Growth
-$55.2M
(-5.9%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
15.65%
Holding
1,097
New
348
Increased
154
Reduced
158
Closed
436
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$13.9M |
| 2 |
CVS Health
CVS
|
+$12.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$11.6M |
| 4 |
Skyworks Solutions
SWKS
|
+$10.5M |
| 5 |
Nike
NKE
|
+$9.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$27.9M |
| 2 |
Starbucks
SBUX
|
+$11.8M |
| 3 |
Goldman Sachs
GS
|
+$10.9M |
| 4 |
Coca-Cola
KO
|
+$8.98M |
| 5 |
T-Mobile US
TMUS
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.88% |
| 3 | Consumer Discretionary | 12.26% |
| 4 | Financials | 8.85% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTLE
301
DELISTED
Vital Energy
VTLE
| $668K | 0.08% |
+12,054
| New | +$647K |
|
302
Archer Aviation
ACHR
$3.78B
| $665K | 0.08% |
+131,459
| New | +$754K |
|
303
Joby Aviation
JOBY
$7.25B
| $662K | 0.08% |
102,700
+46,500
| +83% | +$367K |
|
304
AngloGold Ashanti
AU
$40.7B
| $662K | 0.08% |
+41,921
| New | +$792K |
|
305
Altria Group
MO
$122B
| $660K | 0.08% |
15,700
+8,626
| +122% | +$381K |
|
306
Frontdoor
FTDR
$5.1B
| $657K | 0.08% |
21,478
+11,878
| +124% | +$394K |
|
307
Globus Medical
GMED
$10.6B
| $655K | 0.07% |
+13,191
| New | +$738K |
|
308
XP
XP
$8.65B
| $654K | 0.07% |
28,379
-105,800
| -79% | -$2.65M |
|
309
Dycom Industries
DY
$12.7B
| $650K | 0.07% |
+7,298
| New | +$728K |
|
310
Tapestry
TPR
$29.8B
| $649K | 0.07% |
22,571
+8,600
| +62% | +$315K |
|
311
Expeditors International
EXPD
$22.4B
| $645K | 0.07% |
5,627
+2,927
| +108% | +$348K |
|
|
WW
312
DELISTED
WW International
WW
| $643K | 0.07% |
58,100
-1,019
| -2% | -$10K |
|
313
NovoCure
NVCR
$1.97B
| $641K | 0.07% |
+39,716
| New | +$1.15M |
|
314
iShares US Real Estate ETF
IYR
$4.73B
| $641K | 0.07% |
8,200
-5,031
| -38% | -$429K |
|
315
Manhattan Associates
MANH
$9.42B
| $636K | 0.07% |
+3,220
| New | +$628K |
|
316
Newmont
NEM
$98.5B
| $636K | 0.07% |
17,200
-48,100
| -74% | -$1.96M |
|
|
CERE
317
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $630K | 0.07% |
+28,882
| New | +$723K |
|
318
Asana
ASAN
$1.79B
| $630K | 0.07% |
34,402
-2,700
| -7% | -$56.4K |
|
319
Acadia Realty Trust
AKR
$2.99B
| $630K | 0.07% |
+43,895
| New | +$665K |
|
320
Jazz Pharmaceuticals
JAZZ
$16B
| $629K | 0.07% |
4,858
+3,000
| +161% | +$400K |
|
321
Axsome Therapeutics
AXSM
$12.3B
| $628K | 0.07% |
+8,992
| New | +$672K |
|
322
Under Armour Class C
UA
$2.95B
| $625K | 0.07% |
+98,035
| New | +$675K |
|
323
AMC Entertainment Holdings
AMC
$2.24B
| $624K | 0.07% |
78,100
+42,540
| +120% | +$1.26M |
|
324
Crown Holdings
CCK
$12.9B
| $623K | 0.07% |
+7,040
| New | +$631K |
|
|
TPH
325
DELISTED
Tri Pointe Homes
TPH
| $623K | 0.07% |
22,773
+7,773
| +52% | +$239K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Bayesian Capital Management held 1,097 positions worth $876M, down 5.9% from $931M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bayesian Capital Management's Q3 2023 filing shows 348 new, 154 increased, 158 reduced and 436 closed positions. Its largest new stake was Walt Disney: 162,687 shares worth $13.2M. The largest sale was NVIDIA, an estimated $27.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2023 buy was Walt Disney: 162,687 shares worth $13.2M.
- Bayesian Capital Management added most to CVS Health in Q3 2023, an estimated $12.2M increase.
- Bayesian Capital Management's biggest Q3 2023 reduction was Coca-Cola, cutting an estimated $8.98M.
- Bayesian Capital Management fully exited NVIDIA in Q3 2023, selling an estimated $27.9M.
- Bayesian Capital Management's ten largest holdings make up 16% of its $876M portfolio in Q3 2023.
- Bayesian Capital Management opened 348 new positions and closed 436 in Q3 2023.
- Bayesian Capital Management's portfolio value fell 5.9% quarter-over-quarter to $876M.
Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.